News

Houston, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Shiny Smile Veneers, a US-based provider of custom-made snap-on veneers, has ...
D-Bal – Mimicking the effects of Dianabol, D-Bal boosts nitrogen retention and protein synthesis for rapid muscle growth.
Lulutox Detox Tea officially launches across Ireland, the USA, UK, Australia and Canada. Formulated with natural herbs like ...
Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial statements for the financial year ending December 31, 2024, ...
The gross proceeds to Cidara from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $350.0 million. In addition, Cidara has granted the ...
In connection with the offering, the Company issued 1,180,877 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) at a purchase price of $3.60 per share, ...
Corbus Fireside Chat June 26, 2025, 10:00 a.m. ET Hosted by Biren Amin, Managing Director Pipe Sandler - Healthcare Equity Research ...
Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the closing of its ...
Revuforj (revumenib) is an oral, first-in-class, selective menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene ...
Decision at the highest levels of appeal in the Medicare process establishes medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments.
Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in ...
NeuroPace is pleased to have a financial leader of Patrick’s caliber join the team at a time of such significant opportunity for our RNS System and critical point in our growth trajectory,” said Joel ...